CELEGHINI, Claudio

CELEGHINI, Claudio  

Dipartimento di Medicina Traslazionale e per la Romagna  

Mostra records
Risultati 1 - 20 di 75 (tempo di esecuzione: 0.046 secondi).
Titolo Data di pubblicazione Autore(i) File
Aberrant expression of TRAIL in B chronic lymphocytic leukemia (B-CLL) cells. 2005 Secchiero, Paola; Tiribelli, M; Barbarotto, Elisa; Celeghini, C; Michelutti, A; Masolini, P; Fani...n, R; Zauli, Giorgio file con accesso da definire
Activation of PKC-epsilon counteracts maturation and apoptosis of HL-60 myeloid leukemic cells in response to TNF family members 2009 Gonelli, Arianna; Milani, Daniela; Rimondi, Erika; Voltan, Rebecca; Grill, V; Celeghini, C. file con accesso da definire
Activation of the nitric oxide synthase pathway represents a key component of the TNF-related apoptosis-inducing ligand (TRAIL)-mediated cytotoxicity on hematological malignancies. 2001 Secchiero, Paola; Gonelli, Arianna; Celeghini, Claudio; Mirandola, Prisco; Guidotti, L; Visani, G...; Capitani, Silvano; Zauli, Giorgio file con accesso da definire
All-Trans retinoic acid potentiates megakaryocyte colony formation: in vitro and in vivo effects after administration to acute promyelocytic leukemia patients 1994 Visani, G.; Zauli, G.; Tosi, P.; Ottaviani, E.; Gibellini, D.; Manfroi, S.; Celeghini, C.; Paglia...rini, C.; Bassini, A.; Tura, S. file con accesso da definire
An increased osteoprotegerin serum release characterizes the early onset of diabetes mellitus and may contribute to endothelial cell dysfunction 2006 Secchiero, Paola; Corallini, Federica; Pandolfi, A; Consoli, A; Candido, R; Fabris, B; Celeghini,... C; Capitani, Silvano; Zauli, Giorgio file con accesso da definire
An update on the xenograft and mouse models suitable for investigating new therapeutic compounds for the treatment of B-cell malignancies 2008 Macor, P.; Secco, E.; Zorzet, S.; Tripodo, C.; Celeghini, C.; Tedesco, F. file con accesso da definire
Anti-leukemic activity of Dasatinib in both p53(wild-type) and p53 (mutated) B malignant cells. 2012 Bosco, Raffaella; Rabusin, M; Voltan, Rebecca; Celeghini, C; Corallini, Federica; Capitani, Silva...no; Secchiero, Paola file con accesso da definire
Association of PI 3-K with tyrosine phosphorylated Vav is essential for its activity in neutrophil-like maturation of myeloid cells 2004 Bertagnolo, Valeria; Brugnoli, Federica; Marchisio, Marco; Celeghini, Claudio; Carini, Cinzia; Ca...pitani, Silvano
Association of serum tumor necrosis factor-related apoptosis inducing ligand with body fat distribution as assessed by dual X-rays absorptiometry 2014 Cervellati, Carlo; Secchiero, Paola; Bonaccorsi, Gloria; Celeghini, C; Zauli, Giorgio file con accesso da definire
Ceramides as the molecular link between impaired lipid metabolism, saturated fatty acid intake and insulin resistance: are all saturated fatty acids to be blamed for ceramide-mediated lipotoxicity? 2024 Sergi, D.; Zauli, E.; Celeghini, C.; Previati, M.; Zauli, G. file con accesso da definire
Complement component C1q as potential diagnostic but not predictive marker of preeclampsia 2016 Agostinis, C.; Stampalija, T.; Tannetta, D.; Loganes, C.; Vecchi Brumatti, L.; De Seta, F.; Celeg...hini, C.; Radillo, O.; Sargent, I.; Tedesco, F.; Bulla, R.
Design, synthesis and biological characterization of novel mitochondria targeted dichloroacetate-loaded compounds with antileukemic activity 2016 Trapella, Claudio; Voltan, Rebecca; Melloni, Elisabetta; Tisato, Veronica; Celeghini, C; Bianco, ...Sara; Fantinati, Anna; Salvadori, Severo; Guerrini, Remo; Secchiero, Paola; Zauli, Giorgio
Dexamethasone counteracts the anti-osteoclastic, but not the anti-leukemic, activity of TNF-related apoptosis inducing ligand (TRAIL) 2010 Zauli, Giorgio; Rimondi, Erika; Celeghini, C; Milani, Daniela; Secchiero, Paola file con accesso da definire
Differential effects of chemotherapeutic drugs versus the MDM-2 antagonist nutlin-3 on cell cycle progression and induction of apoptosis in SKW6.4 lymphoblastoid B-cells 2008 Barbarotto, Elisa; Corallini, Federica; Rimondi, Erika; Fadda, Roberto; Mischiati, Carlo; Grill, ...V; Vaccarezza, M; Celeghini, Claudio file con accesso da definire
Differential effects of stromal derived factor-1 alpha (SDF-1alpha) on early and late stages of human megakaryocytic development. 2000 Secchiero, Paola; Celeghini, Claudio; Cutroneo, G; DI BALDASSARRE, A; Rana, R; Zauli, Giorgio file con accesso da definire
Effect of recombinant TRAIL in a murine co-culture system of osteoclastogenesis 2008 Nicolin, V; Narducci, P; Celeghini, C file con accesso da definire
Erythropoietin-induced erythroid differentiation of K562 cells is accompanied by the nuclear translocation of phosphatidylinositol 3-kinase and intranuclear generation of phosphatidylinositol (3,4,5) trisphosphate 2002 Neri, Luca Maria; Bortul, R; Tabellini, G; Borgatti, Paola; Baldini, G; Celeghini, Claudio; Capit...ani, Silvano; Martelli, Am file con accesso da definire
Extracellular Tat activates c-fos promoter in low serum-starved CD4+ T cells 2001 Gibellini, D; Re, Mc; Ponti, C; Celeghini, C; Melloni, E; LA PLACA, M; Zauli, G file con accesso da definire
Fine tuning of protein kinase C (PKC) isoforms in cancer: shortening the distance from the laboratory to the bedside. 2011 Bosco, Raffaella; Melloni, Elisabetta; Celeghini, C; Rimondi, Erika; Vaccarezza, M; Zauli, Giorgio file con accesso da definire
Functional expression of TRAIL and TRAIL-R2 during human megakaryocytic development 2005 Melloni, Elisabetta; Secchiero, Paola; Celeghini, C; Campioni, Diana; Grill, V; Guidotti, L; Zaul...i, Giorgio file con accesso da definire